HIV incidence, retention, and changes of high-risk behaviors among rural injection drug users in Guangxi, China

Substance Abuse

Volumn 27, Issue 4, 2007, Pages 53-61

  Wei, Liu ^a   Chen, Jie ^a   Rodolph, Michelle ^b   Beauchamp, Geetha ^c   Mâsse, Ben ^c   Li, Rongjian ^a   Wang, Shaoping ^d   Ruan, Yuhua ^e   Liu, Shizhu ^e   Zhang, Li ^e   Zhou, Feng ^e   Rose, Scott M ^f   Perdue, Thomas ^c   Lai, Shenghan ^b   Shao, Yiming ^e   Jackson, J Brooks ^b,g  

^a Guangxi Centre for Disease Control   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d Heng County Anti Epidemic Station   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f FAMILY HEALTH INTERNATIONAL   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

China; Guangxi; HIV incidence; IDU; Retention

Indexed keywords

DIAMORPHINE;

ADULT; ANALYTIC METHOD; ARTICLE; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; FEMALE; FOLLOW UP; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; RURAL HEALTH CARE; SELF REPORT; SEROLOGY; SEXUALITY;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV SEROPREVALENCE; HIV-1; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; PATIENT DROPOUTS; PROSPECTIVE STUDIES; RURAL POPULATION; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX;

EID: 33947145700     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1300/J465v27n04_07     Document Type: Article

References (23)

1. The Ministry of Health of the People's Republic of China, Joint United Nations Programme on HIV/ AIDS and World Health Organization: 2005 Update on the HIV/AIDS Epidemic and Response in China; January 24, 2006.
2. Chinese National Center for Disease Control and Prevention: Annual report of National AIDS/STD Surveillance in 2003: Analysis of HIV epidemic in 2003. Beijing: Chinese National Center for Disease Control and Prevention; February, 2004.
3. Ma Y, Li ZZ, Zhao SD. Identification of HIV infection among drug users in China [in Chinese]. Chin J Epidemiol 1990;11: 184-185.
4. The Ministry of Public Security P.R. China: Report on Drug Users in 2002, China. Available at: www. mps.gov.cn/webpage/showNews.asp?id= 1000&biaoshi=bitGreatNews. Accessed June 25, 2003.
5. Beyrer C, Razak MH, Lisam K, et al. Overland heroin trafficking routes and HIV-1 spread in South and South-East Asia. AIDS Research and Human Retroviruses 2000; 14: 75-83.
6. 1st National HIV Molecular Epidemiology of HIV infection in China to Ministry of Science and Technology and Ministry of Health, 1997.
7. Shao YM, Zhao QB, Guo Y. Molecular epidemiology and diversity of HIV-1 strains in Dehong region of Yunnan in Southwest China. 10th International Congress of Virology, Jerusalem, Israel, w62.
8. Qin GM, Shao Y, Liu G. Subtype and sequence analysis of the C2-V3 region of gp120 genes among HIV-1 strains in Sichuan province [in Chinese]. Chin J Epidemiol 1998;19: 39-42.
9. Bai XH, Guan YJ, Zhang YZ, et al. Subtype and sequence analysis of the C2-V3 region of env genes among HIV-1 strains in Urumqi, Xinjiang province. Chinese Journal of Virology. 1997; 13:339-344.
10. Shao YM, Zhao F, Yang WZ, Gung XC. The identification of recombinant HIV-1 strains in IDUs in southwest and northwest China. Chinese Journal of Experimental and Clinical Virology 1999; 13:109-112.
11. Lai S, Chen J, Celentano D, et al. Adoption of injection practices in heroin users in Guangxi Province, China. Journal of Psychoactive Drugs 2000;32: 285-292.
12. Lai S, Liu W, Chen J, et al. Changes in HIV-1 incidence in heroin users in Guangxi Province, China. Journal Acquired Immune Deficiencies Syndromes 2001; 26: 365-370.
13. Guangxi Public Health Department: Annual Report on Provincial AIDS/STD Surveillance in 2003, February 2004.
14. Messiah A, Navaline H, Davis-Vogel A, Tobin-Fiore D, Metzger D. Sociodemographic and behavioral characteristics associated with timeliness and retention in a 6-month follow-up study of high-risk injection drug users. Am J Epidemiol 2003; 157:930-939.
15. Cottler LB, Compton WM, Ben-Abdallah A, Horne M, Claverie D. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend 1996; 41:209-217.
16. Baldwin JA, Bowen AM, Trotter RT, II. Factors contributing to retention of not-in-treatment drug users in an HIV/AIDS Outreach Prevention Project. Drugs & Society 1996; 9:19-35.
17. Des Jarlais DC, Marmor M, Friedman P, et al. HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic. Am J Public Health 2000; 90:352-359.
18. NIMH Multisite HIV Prevention Trial. Screening, recruiting and predicting retention of participants in amultisite HIV prevention trial. AIDS 1997; 11:S13-S19.
19. Nelson K, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D, et al. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol 2002; 156:641-653.
20. Coutinho RA. Needle exchange, pragmatism, and moralism.AmJ Public Health 2000; 90:1387-1388.
21. Ball AL, Rana S, Dehne K. HIV prevention among injecting drug users: Responses in developing and transitional countries. Public Health Rep 1998; 113 (suppl 1):170-181.
22. Kitayaporn D, Uneklabh C, Weniger BG, et al. HIV-1 incidence determined retrospectively among IDU in Bangkok, Thailand. AIDS 1994;8:1443-1450.
23. Stimson GV, Des Jarlais DC, Ball A, eds. Drug injecting and HIV infection: global dimensions and local responses. London: UCL Press, 1998.